BMP-2 Binding to Native Glycosaminoglycans in Decellularized Matrix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current osteogenic compositions face limitations in retaining therapeutic factors locally and promoting effective tissue formation due to inadequate cooperative interaction between osteogenic factors and carriers, leading to insufficient bone regeneration in medical procedures.
Innovation Solution
The use of collagenous extracellular matrix tissue materials that retain native sulfated glycosaminoglycans, such as heparin or heparan sulfate, to bind bone morphogenic proteins like BMP-2, enhancing bioactivity and tissue formation, combined with erythropoietin to stimulate bone remodeling and angiogenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional carriers (e.g., collagen sponge, hydrogels, bioceramics) are used to deliver osteogenic factors, then the therapeutic factor can be delivered to the desired tissue, but the carrier fails to retain the therapeutic factor locally for a sufficient period of time
Solution Approach 1:
The patent uses a composite material consisting of demineralized bone matrix (organic phase) and bioceramic particles (inorganic phase). The bioceramic particles provide structural support and osteoconduction, while the demineralized bone matrix contains native proteins and growth factors that bind and retain the recombinant human BMP-2. This composite structure enables both sustained local retention of the osteogenic factor and reliable bone regeneration, resolving the contradiction between retention duration and regeneration effectiveness.
2Duration of action of stationary object
If conventional carriers are used to deliver osteogenic factors, then delivery to desired tissue is achieved, but the carrier fails to resorb well in the host
Solution Approach 1:
The demineralized bone matrix carrier is designed to be temporarily present and then resorbable. The organic matrix components and bound growth factors are gradually released and utilized by host cells for bone formation, while the bioceramic framework remains as a permanent scaffold. This discarding-recovering mechanism allows the carrier to fulfill its delivery function temporarily, then integrate seamlessly into the host tissue through controlled resorption, resolving the contradiction between resorption time and tissue integration.
3Productivity
If conventional carriers are used, then osteogenic factor delivery is achieved, but there is lacking cooperative interaction among the osteogenic factor and the carrier to enhance tissue formation
Solution Approach 1:
The demineralized bone matrix contains native bone proteins and growth factors that naturally bind to and activate the recombinant human BMP-2. This self-service mechanism creates cooperative interaction where the carrier components work synergistically with the osteogenic factor to enhance bone formation without requiring complex external control systems. The native bone matrix automatically provides the biochemical environment needed for BMP-2 activity, resolving the contradiction between bone formation rate and interaction complexity.
Data Source
Figure 1A~1B
AI summary
Osteogenic compositions include a decellularized extracellular matrix tissue and bone morphogenic protein, preferably BMP-2. The compositions make beneficial use of the BMP, which can be used at relatively low doses and can bind to native components (e.g., native sulfated glycosaminoglycans such as heparin and/or heparan sulfate) remaining in the decellularized extracellular matrix tissue. Methods for preparation and use of such compositions are also described. The compositions and related methods can be used in the treatment of diseased or damaged bone tissue.